Healthcare Business Strategy

Podcast

Improve CAHPS through Enhanced Benefits Navigation

Anne Tumlinson joined healthcare leaders from Alignment Health, SCAN, and Dina about the importance of Medicare Advantage plans to ensure members understand available non-medical benefits. Making the experience painless is essential to attracting and retaining members – and improving CAHPS and Star Ratings. This session is packed with successful strategies and best practices plans can implement to improve member experience and ensure members receive the care they need. Panelists discuss humanizing the navigation process; creating a culture of customer service, streamlining technology to benefit navigation, and leveraging home-centered care.
Read More Read More
News

More Medicare Advantage Plans Are Offering Extra Supports For Frail Seniors

Forbes recently picked up work created by ATI Advisory to support the assertion of a column on the value of offering beneficiaries supplemental benefits.
Read More Read More
News

CMS Data Shows SNFs a ‘Good Landing Spot’ For Less Acute Patients, Emboldens Calls for Ending 3-Day Stay Rule

Fred Bentley comments on the Centers for Medicare and Medicaid Services' preliminary analysis on waiver use and direct admits to SNFs in Skilled Nursing News.
Read More Read More
Work

Medicare Advantage Enrollment Trends – February 2023

Analysis of national Medicare Advantage enrollment data between 2022 and 2023 shows that Medicare Advantage gained more than two million enrollees, reaching more than 47% of the Medicare eligible population. Medicare Fee-For-Service enrollment data showed 800,000 fewer enrollees over the same period.
Read More Read More
News

Waiver of 3-day stay didn’t increase costs or lower outcomes in CMS study

Fred Bentley quoted in McKnight's Long-Term Care News about the value of SNFs for certain patients.
Read More Read More
News

CMS to work closely with FDA on accelerated approval payment reforms

Anna Kaltenboeck spoke to Endpoints News about CMMI's proposed demo for accelerated approval drugs. Whatever reimbursement benchmark they use will drive provider and manufacturer response.
Read More Read More
1 2 3 7